2013
DOI: 10.1001/jama.2013.7271
|View full text |Cite
|
Sign up to set email alerts
|

Management Setting of Obstructive Sleep Apnea

Abstract: Obstructive sleep apnea (OSA) is associated with cognitive impairment, daytime sleepiness, and cardiovascular and cerebrovascular morbidity and mortality. Continuous positive airway pressure (CPAP) remains the primary treatment for this disorder, and recent data provide novel insight regarding optimal CPAP application and compliance. Promising alternate forms of OSA treatment have also been addressed with recent clinical research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
3
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…Therefore, the study of Chai-Coetzer was likely underpowered to demonstrate a difference in the PAP adherence metric. Additionally, as noted by Weingarten and Basner, 8 study withdrawal was 2-3 fold higher in primary care versus specialist groups, with nearly half of the withdrawals in the primary care group due to PAP intolerance. Demonstrating non-inferior reduction in subjective sleepiness as determined by ESS in OSA in a tightly controlled protocol managed by primary care physicians and allied health providers relative to sleep specialist should not be interpreted as providing equivalent PAP adherence and cardiovascular risk reduction.…”
mentioning
confidence: 57%
See 2 more Smart Citations
“…Therefore, the study of Chai-Coetzer was likely underpowered to demonstrate a difference in the PAP adherence metric. Additionally, as noted by Weingarten and Basner, 8 study withdrawal was 2-3 fold higher in primary care versus specialist groups, with nearly half of the withdrawals in the primary care group due to PAP intolerance. Demonstrating non-inferior reduction in subjective sleepiness as determined by ESS in OSA in a tightly controlled protocol managed by primary care physicians and allied health providers relative to sleep specialist should not be interpreted as providing equivalent PAP adherence and cardiovascular risk reduction.…”
mentioning
confidence: 57%
“…6 The investigators conducted a comparison of within-trial sleep diagnostic and treatment cost and report a total average cost per randomized patient of $1819.44 in the primary care group and $3067.86 in the sleep specialist group. Although the investigation has signifi cant limitations 7,8 that make the conclusions diffi cult to extrapolate to the general population and to healthcare systems outside of Australia, the data nonetheless question the value of specialty care in the diagnosis and management of OSA. It appears that what was once not so complicated is, in fact, now complicated and controversial.…”
mentioning
confidence: 99%
See 1 more Smart Citation